Stop looking for answers,
innovate with the right partner

Seeking Respiratory Solutions and Technologies

• Posted by The Procter & Gamble Company
• ·
• Project Size : 250,000 - 1,000,000 €

Our preference is to find opportunities that are on-market, market-ready, or require limited development. Opportunities may consist of new product forms, packaging innovations, delivery technologies, or new products.

Seeking Oral Care Solutions with Seal and Protect Benefit

• Posted by The Procter & Gamble Company
• ·
• Project Size : 250,000 - 1,000,000 €

Products, technologies or ingredients that (a) provide a layer, barrier or coating which will inhibit the formation of plaque or biofilm on tooth surfaces and/or (b) provide a coating to protect the teeth from stain and erosive acids or deliver effective amounts of oral care ingredient for an extended period of time.

Seeking Grooming Solutions

• Posted by The Procter & Gamble Company
• ·
• Project Size : 50,000 - 250,000 €

Grooming technology solutions that remove, trim, shape or style hair from the body and face, in safe, convenient ways that are achievable at home.

"No-Noble-Metal" Catalytic trap to remove Hydrocarbons, NOx and CO emissions from combustion engines

• Posted by Universidad de Alicante
• ·
• Patents for licensing

A Spanish research group has developed a new non-noble metal-based catalyst to remove the emission of hydrocarbons (HC) in internal combustion engines. A patent for this technology has been applied for. The material, which has been developed at laboratory scale, can act as a HC trap and as an oxidation catalyst during the whole cold start cycle of the engine.

Shimmer3 Bioimpedance Monitor - Monitoring HR, respiration rate and depth, and the increase in fluid in the lungs to triage and remotely monitor Covid-19 patients

• Posted by shimmer Research
• ·
• Innovative Products and Technologies

Managing the huge influx of patients in hospitals is one of the most critical challenges of the current COVID-19 pandemic. Shimmer’s Bioimpedance Monitor has the potential to help manage this challenge by monitoring HR, respiration rate and depth and the increase in fluid in the lungs to triage and remotely monitor patients. Background Bioimpedance, specifically across the lungs, has long been studied in Chronic Heart Failure (CHF) and Acute Respiratory Distress Syndrome (ARDS). This measurement provides useful indicators of respiration, including rate, volume, and fluid in the lungs. Because COVID-19 attacks the lungs, these measurements provide clear indications of the progression of the disease. This information can be used in many ways, potentially including: • Monitoring patients remotely at home to determine, if and when, they will need to be admitted to the hospital • Monitoring patients in a hospital to determine when they need more aggressive treatment (e.g., ventilators) • Enabling the earlier release of non-acute patients because of the ability to monitor at home • Adjusting the treatment depending on the rate of progression of disease

Photocatalytic water splitting using IEF 11 and 13

• Posted by IMDEA Energy
• ·
• Innovative Products and Technologies

IMDEA-Energy Frameworks (IEFs) have emerged as potential platforms for hydrogen generation because the easy tunability of their electrochemical properties compared to other semiconductors. Here, we propose two new competitive porous polymers, i.e. IEF-11 and IEF-13, showing improved performance in green hydrogen generation compared to conventional TiO2.